LONG-TERM TREATMENT OF HYPERLIPOPROTEINEMIA, TYPE-IIA AND TYPE-IIB WITH ETIROXATE

被引：6
|
作者：
SCHWARTZKOPFF, W [1 ]
RUSS, E [1 ]
机构：
[1] FREIEN UNIV BERLIN, KLIN WESTEND,MED KLIN & POLIKLIN, FETTSTOFFWECHSELAMBULANZ,SPANDAUER DAMM 130, 1 BERLIN 19, FED REP GER
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 1975年 / 100卷 / 15期
关键词：
D O I：
10.1055/s-0028-1106301
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：815 / 821
页数：7
相关论文
共 50 条
  • [1] DOSAGE-ACTIVITY COMPARISON WITH ETIROXATE HCL IN HYPERLIPOPROTEINEMIA TYPE-IIA AND TYPE-IIB
    BANZ, H
    GALL, FP
    [J]. MEDIZINISCHE KLINIK, 1980, 75 (01) : 51 - 52
  • [2] LONG-TERM STUDY WITH ETOFIBRATE IN PATIENTS WITH HYPERLIPOPROTEINEMIA TYPE-IIA AND IIB
    SPOTTL, F
    FROSCHAUER, J
    HAASE, W
    [J]. HERZ KREISLAUF, 1976, 8 (12): : 710 - 714
  • [3] THERAPEUTIC EFFECTS OF BEZAFIBRATE AND GEMFIBROZIL IN HYPERLIPOPROTEINEMIA TYPE-IIA AND TYPE-IIB
    KREMER, P
    MAROWSKI, C
    JONES, C
    ACACIA, E
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 1989, 11 (05) : 293 - 303
  • [4] PLATELET MEMBRANE FLUIDITY IN TYPE-IIA, TYPE-IIB AND TYPE-IV HYPERLIPOPROTEINEMIA
    MALLE, E
    SATTLER, W
    PRENNER, E
    LEIS, HJ
    KARADI, I
    KNIPPING, G
    ROMICS, L
    KOSTNER, GM
    [J]. ATHEROSCLEROSIS, 1991, 87 (2-3) : 159 - 167
  • [5] COMPARATIVE-STUDY OF CLOFIBRATE AND BEZAFIBRATE IN HYPERLIPOPROTEINEMIA TYPE-IIA AND TYPE-IIB
    ARNTZ, HR
    KLEMENS, UH
    LANG, PD
    VOLLMAR, J
    [J]. MEDIZINISCHE KLINIK, 1978, 73 (49) : 1731 - 1737
  • [6] COMBINED PARA-AMINOSALICYLIC ACID AND DIETARY THERAPY IN LONG-TERM CONTROL OF HYPERCHOLESTEROLEMIA AND HYPERTRIGLYCERIDEMIA (TYPE-IIA AND TYPE-IIB HYPERLIPOPROTEINEMIA)
    KUO, PT
    FAN, WC
    KOSTIS, JB
    HAYASE, K
    [J]. CIRCULATION, 1976, 53 (02) : 338 - 341
  • [7] CHOLESTYRAMINE, CLOFIBRATE AND NICOTINIC-ACID AS SINGLE OR COMBINED TREATMENT OF TYPE-IIA AND TYPE-IIB HYPERLIPOPROTEINEMIA
    ORO, L
    OLSSON, AG
    ROSSNER, S
    CARLSON, LA
    [J]. POSTGRADUATE MEDICAL JOURNAL, 1975, 51 : 76 - 81
  • [8] HEPATOCYTES AND EARLY TYPE-IIA AND TYPE-IIB HYPERLIPOPROTEINEMIAS
    GARIOT, P
    GROSS, P
    FOLIGUET, B
    KOLOPP, M
    BARRAT, E
    POINTEL, JP
    DROUIN, P
    DEBRY, G
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 1985, 43 (04) : 679 - 679
  • [9] EFFECTS OF MEDIUM-TERM PROBUCOL TREATMENT ON PLASMA-LIPIDS AND LIPOPROTEINS - 16 CASES OF TYPE-IIA AND TYPE-IIB HYPERLIPOPROTEINEMIA
    ROUFFY, J
    CHANU, B
    BAKIR, R
    GOYLOEPPER, J
    SAYA, C
    [J]. NOUVELLE PRESSE MEDICALE, 1980, 9 (40): : 3014 - 3017
  • [10] RENAL-FUNCTION IN PATIENTS WITH TYPE-IIA AND TYPE-IIB HYPERLIPEMIA
    FERDER, L
    INSERRA, F
    RYBA, D
    DACCORDI, H
    LIPSZYC, P
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (01) : 274 - 274
12345